SCHEMBL585347

SCHEMBL585347

[S]Sc1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29896037 0.81 ALDH1A1 (0.50)
SCHEMBL9548473 0.81 CYP2A6 (0.50)
SCHEMBL2829221 0.81 ALDH1A1 (0.50)
Hydrochloric Acid SCHEMBL30967433 0.79 ALDH1A1 (0.48)
Hydrochloric Acid SCHEMBL10942983 0.79 ALDH1A1 (0.48)
SCHEMBL23183097 0.77
SCHEMBL272036 0.77
SCHEMBL21415461 0.77
Ethyne SCHEMBL17596309 0.77 ALDH1A1 (0.46)
SCHEMBL12317161 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251409-A1 Targeted Delivery of Factor VIII Proteins to Platelets NOVO NORDISK AS (DK) 2016-09-01 US disclosed
EP-2417155-B1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS NOVO NORDISK AS (DK) 2013-06-19 EP disclosed
US-20120093840-A1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS NOVO NORDISK A/S (DK) 2012-04-19 US disclosed
EP-2417155-A1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS Novo Nordisk A/S (DK) 2012-02-15 EP disclosed
WO-2010115866-A1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS NOVO NORDISK A/S (DK) 2010-10-14 WO disclosed